Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tyra Biosciences, Inc. Director's Dealing 2021

Sep 17, 2021

32575_dirs_2021-09-17_f987b0a0-db31-48c8-bc61-95dfb0882e7b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tyra Biosciences, Inc. (TYRA)
CIK: 0001863127
Period of Report: 2021-09-17

Reporting Person: Boxer Capital, LLC (10% Owner)
Reporting Person: Boxer Asset Management Inc. (10% Owner)
Reporting Person: LEWIS JOSEPH (10% Owner)
Reporting Person: MVA Investors, LLC (10% Owner)
Reporting Person: Davis Aaron I. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-09-17 Common Stock C 5698359 Acquired 5698359 Direct
2021-09-17 Common Stock P 625000 $16.00 Acquired 6323359 Direct
2021-09-17 Common Stock C 288095 Acquired 288095 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-09-17 Series A Preferred Stock $ C 1480242 Disposed Common Stock (3844780) Direct
2021-09-17 Series A Preferred Stock $ C 95516 Disposed Common Stock (248093) Direct
2021-09-17 Series B Preferred Stock $ C 713629 Disposed Common Stock (1853579) Direct
2021-09-17 Series B Preferred Stock $ C 15401 Disposed Common Stock (40002) Direct

Footnotes

F1: On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into shares of the Issuer's common stock at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.

F2: These securities are held directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Joseph C. Lewis, (iv) MVA Investors, LLC and (v) Aaron I. Davis (collectively, the "Boxer Group"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.

F3: These securities are held directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.